Adverse experiences with implantable defibrillators in Oregon hospices

Erik Fromme, Tanya Stewart, Margaret Jeppesen, Susan Tolle

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: Implantable cardioverter-defibrillators (ICDs) improve survival in patients at risk for recurrent, sustained ventricular tachycardia or fibrillation. Unless deactivated, ICDs may deliver unwanted shocks to terminally ill patients near the time of death. This study sought to determine the frequency and nature of adverse experiences with ICDs in hospice programs and what preventative measures the programs had taken. Method: A mailed survey to all 50 Oregon Hospice Programs in August 2008. Results: 42 (84%) of 50 programs participated. In all 36 (86%) of 42 programs reported having taken care of a patient with an ICD in the preceding 4 years. The average number of patients with ICDs per program increased from 2.2 (SD 2.5) in 2005 and 2006 to 3.6 (SD 3.7) in 2007 and 2008. Of the 36 programs who had cared for a patient with an ICD, 31 (86%) reported having some kind of adverse experience. These ranged from unwanted shocks delivered (64%), patient/family distress related to the decision to deactivate the ICD (47%), and time delay in ICD deactivation (42%). Only 16 (38%) programs had policies for managing ICDs and only 19 (43%) routinely screened new patients for ICDs. Discussion: As patients near the end of their lives, receiving defibrillating shocks may no longer be consistent with their goals of care. Based on the high frequencies of potentially preventable adverse outcomes documented by this study, we propose that hospices routinely screen patients for ICDs and proactively adopt policies to manage them, rather than in response to an adverse event.

Original languageEnglish (US)
Pages (from-to)304-309
Number of pages6
JournalAmerican Journal of Hospice and Palliative Medicine
Volume28
Issue number5
DOIs
StatePublished - Aug 2011

Fingerprint

Hospices
Implantable Defibrillators
Hospice Care
Shock
Patient Care Planning
Terminally Ill
Ventricular Fibrillation
Ventricular Tachycardia
Patient Care
Outcome Assessment (Health Care)

Keywords

  • adverse effects
  • cross-sectional studies
  • defibrillators-implantable
  • hospice care
  • terminal care

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Adverse experiences with implantable defibrillators in Oregon hospices. / Fromme, Erik; Stewart, Tanya; Jeppesen, Margaret; Tolle, Susan.

In: American Journal of Hospice and Palliative Medicine, Vol. 28, No. 5, 08.2011, p. 304-309.

Research output: Contribution to journalArticle

Fromme, Erik ; Stewart, Tanya ; Jeppesen, Margaret ; Tolle, Susan. / Adverse experiences with implantable defibrillators in Oregon hospices. In: American Journal of Hospice and Palliative Medicine. 2011 ; Vol. 28, No. 5. pp. 304-309.
@article{9b8a120630944a7988b86fd303eae91d,
title = "Adverse experiences with implantable defibrillators in Oregon hospices",
abstract = "Background: Implantable cardioverter-defibrillators (ICDs) improve survival in patients at risk for recurrent, sustained ventricular tachycardia or fibrillation. Unless deactivated, ICDs may deliver unwanted shocks to terminally ill patients near the time of death. This study sought to determine the frequency and nature of adverse experiences with ICDs in hospice programs and what preventative measures the programs had taken. Method: A mailed survey to all 50 Oregon Hospice Programs in August 2008. Results: 42 (84{\%}) of 50 programs participated. In all 36 (86{\%}) of 42 programs reported having taken care of a patient with an ICD in the preceding 4 years. The average number of patients with ICDs per program increased from 2.2 (SD 2.5) in 2005 and 2006 to 3.6 (SD 3.7) in 2007 and 2008. Of the 36 programs who had cared for a patient with an ICD, 31 (86{\%}) reported having some kind of adverse experience. These ranged from unwanted shocks delivered (64{\%}), patient/family distress related to the decision to deactivate the ICD (47{\%}), and time delay in ICD deactivation (42{\%}). Only 16 (38{\%}) programs had policies for managing ICDs and only 19 (43{\%}) routinely screened new patients for ICDs. Discussion: As patients near the end of their lives, receiving defibrillating shocks may no longer be consistent with their goals of care. Based on the high frequencies of potentially preventable adverse outcomes documented by this study, we propose that hospices routinely screen patients for ICDs and proactively adopt policies to manage them, rather than in response to an adverse event.",
keywords = "adverse effects, cross-sectional studies, defibrillators-implantable, hospice care, terminal care",
author = "Erik Fromme and Tanya Stewart and Margaret Jeppesen and Susan Tolle",
year = "2011",
month = "8",
doi = "10.1177/1049909110390505",
language = "English (US)",
volume = "28",
pages = "304--309",
journal = "American Journal of Hospice and Palliative Medicine",
issn = "1049-9091",
publisher = "SAGE Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Adverse experiences with implantable defibrillators in Oregon hospices

AU - Fromme, Erik

AU - Stewart, Tanya

AU - Jeppesen, Margaret

AU - Tolle, Susan

PY - 2011/8

Y1 - 2011/8

N2 - Background: Implantable cardioverter-defibrillators (ICDs) improve survival in patients at risk for recurrent, sustained ventricular tachycardia or fibrillation. Unless deactivated, ICDs may deliver unwanted shocks to terminally ill patients near the time of death. This study sought to determine the frequency and nature of adverse experiences with ICDs in hospice programs and what preventative measures the programs had taken. Method: A mailed survey to all 50 Oregon Hospice Programs in August 2008. Results: 42 (84%) of 50 programs participated. In all 36 (86%) of 42 programs reported having taken care of a patient with an ICD in the preceding 4 years. The average number of patients with ICDs per program increased from 2.2 (SD 2.5) in 2005 and 2006 to 3.6 (SD 3.7) in 2007 and 2008. Of the 36 programs who had cared for a patient with an ICD, 31 (86%) reported having some kind of adverse experience. These ranged from unwanted shocks delivered (64%), patient/family distress related to the decision to deactivate the ICD (47%), and time delay in ICD deactivation (42%). Only 16 (38%) programs had policies for managing ICDs and only 19 (43%) routinely screened new patients for ICDs. Discussion: As patients near the end of their lives, receiving defibrillating shocks may no longer be consistent with their goals of care. Based on the high frequencies of potentially preventable adverse outcomes documented by this study, we propose that hospices routinely screen patients for ICDs and proactively adopt policies to manage them, rather than in response to an adverse event.

AB - Background: Implantable cardioverter-defibrillators (ICDs) improve survival in patients at risk for recurrent, sustained ventricular tachycardia or fibrillation. Unless deactivated, ICDs may deliver unwanted shocks to terminally ill patients near the time of death. This study sought to determine the frequency and nature of adverse experiences with ICDs in hospice programs and what preventative measures the programs had taken. Method: A mailed survey to all 50 Oregon Hospice Programs in August 2008. Results: 42 (84%) of 50 programs participated. In all 36 (86%) of 42 programs reported having taken care of a patient with an ICD in the preceding 4 years. The average number of patients with ICDs per program increased from 2.2 (SD 2.5) in 2005 and 2006 to 3.6 (SD 3.7) in 2007 and 2008. Of the 36 programs who had cared for a patient with an ICD, 31 (86%) reported having some kind of adverse experience. These ranged from unwanted shocks delivered (64%), patient/family distress related to the decision to deactivate the ICD (47%), and time delay in ICD deactivation (42%). Only 16 (38%) programs had policies for managing ICDs and only 19 (43%) routinely screened new patients for ICDs. Discussion: As patients near the end of their lives, receiving defibrillating shocks may no longer be consistent with their goals of care. Based on the high frequencies of potentially preventable adverse outcomes documented by this study, we propose that hospices routinely screen patients for ICDs and proactively adopt policies to manage them, rather than in response to an adverse event.

KW - adverse effects

KW - cross-sectional studies

KW - defibrillators-implantable

KW - hospice care

KW - terminal care

UR - http://www.scopus.com/inward/record.url?scp=80051605307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051605307&partnerID=8YFLogxK

U2 - 10.1177/1049909110390505

DO - 10.1177/1049909110390505

M3 - Article

VL - 28

SP - 304

EP - 309

JO - American Journal of Hospice and Palliative Medicine

JF - American Journal of Hospice and Palliative Medicine

SN - 1049-9091

IS - 5

ER -